Dorman Products director Richard T. Riley reported a small, routine tax-related share disposition. On the vesting of restricted stock units, 33 shares of Common Stock were withheld by the company at $116.16 per share to satisfy his tax withholding obligations. After this withholding, he directly holds 28,968 Common shares, so the transaction represents a very minor adjustment tied to equity compensation rather than an open-market trade.
Dorman Products, Inc. director Lisa M. Bachmann reported a small tax-related share disposition tied to vested equity. On the vesting of restricted stock units, 33 shares of common stock were withheld by the company at $116.16 per share to cover her tax obligations, leaving her with 6,864 directly held shares.
Dorman Products, Inc. director Kelly A. Romano reported a small, routine tax-related share disposition. On the vesting of restricted stock units, 33 shares of common stock were withheld by the company at $116.16 per share to satisfy tax withholding obligations, which is treated as a disposition under Section 16. After this withholding, Romano directly holds 10,828 shares of Dorman Products common stock.
Dorman Products, Inc. director Thomas James Darrell reported a small tax-related share disposition. On the vesting of restricted stock units, 33 shares of common stock were withheld by the company at $116.16 per share to cover his tax obligations, which is classified as a disposition under securities rules. After this withholding, he directly holds 6,574 shares of Dorman common stock.
Dorman Products, Inc. held its 2026 Annual Meeting of Shareholders on May 15, 2026. Shareholders voted on director elections, executive pay, auditor ratification, and a new incentive plan.
All eight director nominees were elected, each receiving over 25.9 million votes in favor, with broker non-votes of 1,514,853 on each election. Shareholders approved, on an advisory basis, the compensation of named executive officers with 26,322,500 votes in favor versus 1,042,754 against. They also ratified KPMG LLP as independent registered public accounting firm for 2026 with 28,315,138 votes in favor. In addition, the Dorman Products, Inc. 2026 Omnibus Incentive Plan was approved, receiving 27,005,093 votes in favor against 364,902 votes opposed.
DORM submitted a Form 144 notice listing proposed sales of Common stock. The filing shows option-related line items dated 05/06/2026 and identifies two option grants with quantities 623 and 703 shares. The notice lists $165,750.00 alongside other filing fields and references Fidelity Brokerage Services LLC.
Dorman Products, Inc. reported higher sales but lower profit for the quarter ended March 28, 2026. Net sales rose to $528.8 million from $507.7 million, driven mainly by tariff-related price increases, while volumes softened versus a strong prior-year period.
Profitability declined as gross margin fell to 36.0% from 40.9%, primarily due to higher tariff costs despite supplier diversification, productivity, and automation efforts. Net income dropped to $43.6 million from $57.5 million, with diluted EPS down to $1.43 from $1.87.
Cash from operations was $43.8 million, helped by inventory reductions but pressured by lower earnings and reduced receivables factoring. Dorman repurchased 435,174 shares for $51.4 million and ended the quarter with $43.1 million in cash, $455.6 million of debt, and $583.9 million available under its credit facility.
Dorman Products reported first-quarter 2026 net sales of $528.8 million, up 4.2% from $507.7 million a year earlier, as demand grew across its segments. Net income was $43.6 million and diluted EPS was $1.43, down 24% from $1.87, mainly due to higher tariff-related costs. Adjusted diluted EPS was $1.57, down 22% from $2.02. Gross margin declined to 36.0% of sales from 40.9%, while SG&A leverage modestly improved on an adjusted basis. The company generated $43.8 million of operating cash flow and repurchased $51 million of shares at an average price of $118. For full-year 2026, Dorman reaffirmed guidance for net sales growth of 7%–9%, GAAP diluted EPS of $7.57–$7.97, and adjusted diluted EPS of $8.10–$8.50.
Vanguard Portfolio Management reports beneficial ownership of 1,528,639 shares of Dorman Products Inc Common Stock, representing 5.06% of the class as of 03/31/2026. The filing lists 23,999 shares of sole voting power and 1,528,639 shares of sole dispositive power. The disclosure states these holdings include securities held for Vanguard funds and managed accounts for which Vanguard Portfolio Management LLC or its affiliates exercise dispositive power.